| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SMMT | Common Stock | Purchase | $22,599,706 | +21,523,530 | $1.05 | 21,523,530 | 07 Mar 2023 | Akeso, Inc. | F1, F3 | |
| transaction | SMMT | Common Stock | Purchase | $25,100,000 | +10,000,000 | $2.51 | 10,000,000 | 17 Jan 2023 | Akeso, Inc. | F2, F3 |
| Id | Content |
|---|---|
| F1 | 21,523,530 shares of the Issuer's Common Stock were acquired on March 7, 2023 through a rights offering. |
| F2 | 10,000,000 shares of the Issuer's Common Stock were issued on January 17, 2023 in connection with the Collaboration and License Agreement with Akeso, Inc.("Akeso") pursuant to which the Issuer issued Akeso such shares. |
| F3 | Akeso is the direct beneficial owner of the shares of the Issuer's Common Stock. Dr. Xia is a stockholder and exercises the right to vote approximately 28.9% of Akeso's ordinary shares, and serves as chairwoman, president and chief executive officer of Akeso. Dr. Xia disclaims beneficial ownership of the shares of Issuer's Common Stock beneficially owned by Akeso, except to the extent of her pecuniary interest. |